Author:
Nakamura Kogenta,Ikawa Kazuro,Nishikawa Genya,Kobayashi Ikuo,Narushima Masahiro,Muramatsu Hiroyuki,Morinaga Shingo,Kajikawa Keishi,Kato Yoshiharu,Watanabe Masahito,Zennami Kenji,Kanao Kent,Morikawa Norifumi,Sumitomo Makoto
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference14 articles.
1. In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone;Nomura;Jpn J Antibiot,2002
2. Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate;Minami;Folia Pharmacol Jpn,2003
3. Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats;Hasegawa;Antimicrob Agents Chemother,1995
4. Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery;Uegami;J Chemother,2014
5. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin;Drusano;Antimicrob Agents Chemother,2000
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献